1
|
Lin CW, Lin PY, Hsu YW, Pan TM, Lee CL. Monascus-fermented metabolites repressed amyloid β-peptide-induced neurotoxicity and inflammatory response in in vitro and in vivo studies. J Funct Foods 2023. [DOI: 10.1016/j.jff.2023.105509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/28/2023] Open
|
3
|
Wang YR, Liu SF, Shen YC, Chen CL, Huang CN, Pan TM, Wang CK. A randomized, double-blind clinical study to determine the effect of ANKASCIN 568 plus on blood glucose regulation. J Food Drug Anal 2017; 25:409-416. [PMID: 28911684 PMCID: PMC9332536 DOI: 10.1016/j.jfda.2016.06.011] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2016] [Revised: 06/12/2016] [Accepted: 06/27/2016] [Indexed: 12/21/2022] Open
Abstract
Diabetes is the fourth major cause of death in Taiwan. High blood glucose can lead to macrovascular diseases,small vessel diseases (retinopathy, kidney disease), and neuropathy. This study aimed to investigate whether Monascus-fermented products (ANKASCIN 568 plus) can regulate blood glucose and blood lipids. This study enrolled 39 patients with a fasting blood glucose level between 100 mg/dL and 180 mg/dL, and a glycated hemoglobin (HbA1c) level of <9%. All patients were randomly divided into placebo (n = 20) and experimental (n = 19) groups. Each patient received two placebo capsules (maltodextrin) or ANKASCIN 568 plus capsules daily for 12 weeks. The patients were screened during follow-up 4 weeks after the administration of sample or placebo had been discontinued. Blood and urine samples were collected at the initial, 6th week, 12th week, and 16th week. The anthropometric indicators of blood pressure, fasting plasma glucose level, postprandial plasma glucose level, insulin level, insulin resistance, blood lipid changes, and liver, kidney, and thyroid function indices were measured. After 6weeks, changes in fasting blood glucose, low-density lipoprotein cholesterol (LDL-C),and total cholesterol (TC) levels showed thatANKASCIN568 plus had amore favorable effect than the placebo. Compared to baseline, a statistically significant decrease of 8.5%, 10.3%, and 7.5% was observed in fasting blood glucose, LDL-C and, TC levels, respectively (p < 0.05 for all pairs). Therefore, ANKASCIN568 plus produced by Monascus purpureus NTU 568 fermentation may be a potentially useful agent for the regulation of blood glucose and blood lipids and for treatment of coronary artery diseases.
Collapse
Affiliation(s)
- Yin-Ruei Wang
- School of Nutrition, Chung Shan Medical University, Taichung,
Taiwan
| | - Sheng-Fu Liu
- School of Nutrition, Chung Shan Medical University, Taichung,
Taiwan
| | - You-Cheng Shen
- School of Health and Diet Industry Management, Chung Shan Medical University, Taichung,
Taiwan
| | - Chien-Li Chen
- Department of Research and Development Division, SunWay Biotech Co., Ltd., Taipei,
Taiwan
| | - Chine-Ning Huang
- School of Medicine, Chung Shan Medical University, Taichung,
Taiwan
- Corresponding authors. Department of Biochemical Science and Technology, College of Life Science, National Taiwan University, Number 1, Section 4, Roosevelt Road, Taipei 10617, Taiwan. E-mail address: (T.-M. Pan)
| | - Tzu-Ming Pan
- Department of Biochemical Science and Technology, College of Life Science, National Taiwan University, Taipei,
Taiwan
- Corresponding authors. Department of Biochemical Science and Technology, College of Life Science, National Taiwan University, Number 1, Section 4, Roosevelt Road, Taipei 10617, Taiwan. E-mail address: (T.-M. Pan)
| | - Chin-Kun Wang
- School of Nutrition, Chung Shan Medical University, Taichung,
Taiwan
- Corresponding authors. Department of Biochemical Science and Technology, College of Life Science, National Taiwan University, Number 1, Section 4, Roosevelt Road, Taipei 10617, Taiwan. E-mail address: (T.-M. Pan)
| |
Collapse
|
4
|
Chen CL, Pan TM. Effects of red mold dioscorea with pioglitazone, a potentially functional food, in the treatment of diabetes. J Food Drug Anal 2015; 23:719-728. [PMID: 28911488 PMCID: PMC9345458 DOI: 10.1016/j.jfda.2015.04.013] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2014] [Revised: 04/16/2015] [Accepted: 05/05/2015] [Indexed: 11/24/2022] Open
|